Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
March 1, 2019Journal of Pain ResearchOpen Access

APOLLO-1: a randomized placebo and active-controlled phase III study investigating oliceridine (TRV130), a G protein-biased ligand at the -opioid receptor, for management of moderate-to-severe acute pain following bunionectomy

View Full Paper
Ask AI
Bookmark
Share

Authors

EVEugene R. ViscusiThomas Jefferson UniversityFSFranck SkobierandaIonis Pharmaceuticals (United States)DSDavid G. SoergelNovartis (Switzerland)

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Viscusi et al. (2019) studied this question.

synapsesocial.com/papers/69d572bfd9840517963cd5dehttps://doi.org/10.2147/jpr.s171013
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Outcomes After Intravenous Opioids in Emergency Patients: A Prospective Cohort Analysis2009 · 40 citations
  2. 2A Simplified Risk Score for Predicting Postoperative Nausea and Vomiting1999 · 2,140 citations
  3. 3Which Clinical Anesthesia Outcomes Are Important to Avoid? The Perspective of Patients1999 · 836 citations
  4. 4Which Clinical Anesthesia Outcomes Are Important to Avoid? The Perspective of Patients1999 · 698 citations
  5. 5Validity and Interrater Reliability of the Moline-Roberts Pharmacologic Sedation Scale2012 · 9 citations